Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4450915
Max Phase: Preclinical
Molecular Formula: C49H63F3IN7O6S
Molecular Weight: 1062.05
Molecule Type: Unknown
Associated Items:
ID: ALA4450915
Max Phase: Preclinical
Molecular Formula: C49H63F3IN7O6S
Molecular Weight: 1062.05
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCCCCCCCCCNCCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1
Standard InChI: InChI=1S/C49H63F3IN7O6S/c1-31-44(67-30-56-31)33-17-15-32(16-18-33)28-55-47(64)40-27-35(61)29-60(40)48(65)45(49(2,3)4)58-41(62)14-11-9-7-5-6-8-10-12-23-54-24-13-25-66-59-46(63)36-20-21-37(50)42(52)43(36)57-39-22-19-34(53)26-38(39)51/h15-22,26,30,35,40,45,54,57,61H,5-14,23-25,27-29H2,1-4H3,(H,55,64)(H,58,62)(H,59,63)/t35-,40+,45-/m1/s1
Standard InChI Key: JGSXZCFNVMIZGE-RIXQQIMYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1062.05 | Molecular Weight (Monoisotopic): 1061.3557 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wei J, Hu J, Wang L, Xie L, Jin MS, Chen X, Liu J, Jin J.. (2019) Discovery of a First-in-Class Mitogen-Activated Protein Kinase Kinase 1/2 Degrader., 62 (23): [PMID:31730343] [10.1021/acs.jmedchem.9b01528] |
2. Hu J,Wei J,Yim H,Wang L,Xie L,Jin MS,Kabir M,Qin L,Chen X,Liu J,Jin J. (2020) Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders., 63 (24.0): [PMID:33284613] [10.1021/acs.jmedchem.0c01609] |
Source(1):